BioMarin Pharmaceutical Statistics

Total Valuation

BMV:BMRN has a market cap or net worth of MXN 199.26 billion. The enterprise value is 186.52 billion.

Market Cap	199.26B
Enterprise Value	186.52B

Important Dates

The next estimated earnings date is Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	191.78M
Shares Outstanding	n/a
Shares Change (YoY)	+1.65%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.36M

Valuation Ratios

The trailing PE ratio is 18.61 and the forward PE ratio is 12.02.

PE Ratio	18.61
Forward PE	12.02
PS Ratio	3.30
PB Ratio	1.68
P/TBV Ratio	1.82
P/FCF Ratio	15.62
P/OCF Ratio	13.92
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.96, with an EV/FCF ratio of 14.62.

EV / Earnings	17.42
EV / Sales	3.33
EV / EBITDA	11.96
EV / EBIT	13.72
EV / FCF	14.62

Financial Position

The company has a current ratio of 5.52, with a Debt / Equity ratio of 0.10.

Current Ratio	5.52
Quick Ratio	3.20
Debt / Equity	0.10
Debt / EBITDA	0.73
Debt / FCF	0.96
Interest Coverage	59.71

Financial Efficiency

Return on equity (ROE) is 9.64% and return on invested capital (ROIC) is 7.12%.

Return on Equity (ROE)	9.64%
Return on Assets (ROA)	6.38%
Return on Invested Capital (ROIC)	7.12%
Return on Capital Employed (ROCE)	10.98%
Revenue Per Employee	19.84M
Profits Per Employee	3.52M
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.46

Taxes

In the past 12 months, BMV:BMRN has paid 3.07 billion in taxes.

Income Tax	3.07B
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has decreased by -32.33% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-32.33%
50-Day Moving Average	1,680.82
200-Day Moving Average	1,669.38
Relative Strength Index (RSI)	32.52
Average Volume (20 Days)	191

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.99

Income Statement

In the last 12 months, BMV:BMRN had revenue of MXN 60.30 billion and earned 10.71 billion in profits. Earnings per share was 55.29.

Revenue	60.30B
Gross Profit	48.85B
Operating Income	14.62B
Pretax Income	13.78B
Net Income	10.71B
EBITDA	16.49B
EBIT	14.62B
Earnings Per Share (EPS)	55.29

Full Income Statement

Balance Sheet

The company has 26.01 billion in cash and 12.30 billion in debt, giving a net cash position of 13.70 billion.

Cash & Cash Equivalents	26.01B
Total Debt	12.30B
Net Cash	13.70B
Net Cash Per Share	n/a
Equity (Book Value)	118.41B
Book Value Per Share	617.51
Working Capital	58.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.31 billion and capital expenditures -1.56 billion, giving a free cash flow of 12.76 billion.

Operating Cash Flow	14.31B
Capital Expenditures	-1.56B
Free Cash Flow	12.76B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.01%, with operating and profit margins of 24.25% and 17.76%.

Gross Margin	81.01%
Operating Margin	24.25%
Pretax Margin	22.86%
Profit Margin	17.76%
EBITDA Margin	27.34%
EBIT Margin	24.25%
FCF Margin	21.16%

Dividends & Yields

BMV:BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.65%
Shareholder Yield	n/a
Earnings Yield	5.37%
FCF Yield	6.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BMRN has an Altman Z-Score of 7.57 and a Piotroski F-Score of 7.

Altman Z-Score	7.57
Piotroski F-Score	7